Advance Search

Molecular detection of Trichomonas Vaginalis using 5.8S rRNA gene in reproductive-age women in Erbil city

Hawri M. Jabbary
Department of Medical Laboratory Technology, Erbil Technical Health and Medical College, Erbil Polytechnic University, Kurdistan Region, Iraq.
Zuber Ismail Hassan
Department of Medical Laboratory Technology, Erbil Technical Health and Medical College, Erbil Polytechnic University, Kurdistan Region, Iraq.
Hero Mohammad Ismael
Department of Biology, College of Science, Salahaddin University, Erbil, Kurdistan Region, Iraq.
Keywords:
Copyright and Licensing:

Copyright (c) 2026 Hawri M. Jabbary, Zuber Ismail Hassan , Hero Mohammad Ismael (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Share:
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Background and objective: Trichomoniasis is a parasitice infection that impacts the human reproductive and urinary systems, constituting a significant non-viral sexually transmitted infection globally. The study evaluated the 5.8S rRNA gene as a molecular target for diagnosing T. vaginalis infection among reproductive-age women in Erbil city.

Methods: Vaginal swabs and urine samples from 800 women were examined microscopically and by PCR targeting a 368 bp fragment of the 5.8S rRNA gene.

Results: Thirteen samples (1.63%) tested positive microscopically and were all confirmed by PCR, demonstrating 100% sensitivity and specificity.

All patients with positive microscopic identification were confirmed using the amplification of a 368bpfragment of 5.8S rRNA gene, acquisition of the accession number from the gene bank (NCBI) under accession numbers (PV935463, PX147457, PX147458, PX147459, PX147460, PX147461, PX147462, PX147463, PX147464, PX147465, PX147466, PX147467, PX218319).

Conclusion: Molecular detection targeting the 5.8S rRNA gene offers a highly sensitive and specific diagnostic tool for Trichomonas vaginalis, supporting its use alongside microscopy to improve detection accuracy in clinical settings.

PDF
PDF

Metrics

Metrics Loading ...

References

  1. Patel EU, Gaydos CA, Packman ZR, Quinn TC, Tobian AA. Prevalence and correlates of Trichomonas vaginalis infection among men and women in the United States. Clin Infect Dis. 2018;67(2):211-7. https://doi.org/10.1093/cid/ciy079.
  2. Yang Y, Qu Y, Yan B, Wang C, Liu S. The prevalence trends of Trichomonas vaginalis infection among women in Jingzhou, central of China, 2019–2023. BMC Infect Dis. 2025;25(1):435. https://doi.org/10.1186/s12879-025-10815-8.
  3. Santos MdPSd, Ramos BRdA, Oliveira MLCSd, Tristão AdR, Silva MGd. Prevalence of Trichomonas vaginalis Infection in Women Screened for Precursor Lesions of Cervical Cancer in a Brazilian Population. Microorganisms. 2024;12(10):2032. https://doi.org/10.3390/microorganisms12102032.
  4. Belfort IKP, Cunha APA, Mendes FPB, Galvão-Moreira LV, Lemos RG, de Lima Costa LH, et al. Trichomonas vaginalis as a risk factor for human papillomavirus: a study with women undergoing cervical cancer screening in a northeast region of Brazil. BMC Women's Health. 2021;21(1):174. https://doi.org/10.1186/s12905-021-01320-6.
  5. Osafo KS, Lin W, Dong B, Sun P. Trichomonas vaginalis and human papillomavirus: Association with the microbiota and burden on the cervix. Gynecol Obstet Clin Med. 2023;3(4):207-12. https://doi.org/10.1016/j.gocm.2023.10.002.
  6. Hamar B, Teutsch B, Hoffmann E, Hegyi P, Varadi A, Nyirady P, et al. Trichomonas vaginalis infection is associated with increased risk of cervical carcinogenesis: a systematic review and meta‐analysis of 470 000 patients. Int J Gynaecol Obstet. 2023;163(1):31-43. https://doi.org/10.1002/ijgo.14763
  7. Tian W, Li Y, Zhang Y, Zhang Y, Qin Y, Han Y, et al. Systematic review and meta-analysis of the global prevalence and infection risk factors of Trichomonas vaginalis. Parasite. 2025;32:56. https://doi.org/10.1051/parasite/2025051
  8. Van Gerwen OT, Craig‐Kuhn MC, Jones AT, Schroeder JA, Deaver J, Buekens P, et al. Trichomoniasis and adverse birth outcomes: a systematic review and meta‐analysis. BJOG. 2021;128(12):1907-15. https://doi.org/10.1111/1471-0528.16774
  9. Zhang Z, Li Y, Lu H, Li D, Zhang R, Xie X, et al. A systematic review of the correlation between Trichomonas vaginalis infection and infertility. Acta Tropica. 2022;236:106693. https://doi.org/10.1016/j.actatropica.2022.106693
  10. Bahreini MS, Sedghi S, Badalzadeh Y, Motazedian MH, Shirani M, Jahromi SS, et al. Molecular diagnosis of Trichomonas vaginalis in liquid-based Papanicolaou samples in Shiraz, southern Iran. BMC Womens Health. 2023;23(1):6. https://doi.org/10.1186/s12905-022-02141-x.
  11. El-kareem NMA, Dyab AK, Albalawi NO, El Samea AA, Taha MAA, AlQadeeb H, et al. Microscopic and molecular detection of Trichomonas vaginalis in outpatients seeking medical care in Upper Egypt. Front Microbiol. 2024;15:1499270. https://doi.org/10.3389/fmicb.2024.1499270
  12. Shiluli C, Kamath S, Kanoi BN, Kimani R, Oduor B, M. Abkallo H, et al. Highly sensitive molecular assay based on Identical Multi-Repeat Sequence (IMRS) algorithm for the detection of Trichomonas vaginalis infection. PLoS One. 2025;20(2):e0317958. https://doi.org/10.1371/journal.pone.0317958.
  13. Bruni MP, da Silveira MF, Stauffert D, de Oliveira Bicca GL, Dos Santos CC, da Rosa Farias NA, et al. Aptima Trichomonas vaginalis assay elucidates significant underdiagnosis of trichomoniasis among women in Brazil according to an observational study. Sex Transm Infect. 2019;95(2):129-32. https://doi.org/10.1136/sextrans-2018-053635
  14. Fazlollahpour-Naghibi A, Bagheri K, Almukhtar M, Taha SR, Zadeh MS, Moghadam KB, et al. Trichomonas vaginalis infection and risk of cervical neoplasia: A systematic review and meta-analysis. PLoS One. 2023;18(7):e0288443. https://doi.org/10.1371/journal.pone.0288443.
  15. Surya NL, Suji T, Rani S, Dorathy I, Minz S, Sahni RD. Trichomonas vaginalis: comparison of primers for implementation as an in-house PCR in rural Vellore, South India. BMC Infect Dis. 2024;24(1):1039. https://doi.org/10.1186/s12879-024-09619-z
  16. Felleisen R. Comparative sequence analysis of 5• 8S rRNA genes and internal transcribed spacer (ITS) regions of trichomonadid protozoa. Parasitology. 1997;115(2):111-9. https://doi.org/10.1017/s0031182097001212
  17. Korycińska J, Dzika E, Waśniewski T, Lepczyńska M, Kubiak K. The prevalence of Trichomonas vaginalis infections in the population of Warmińsko-Mazurskie voivodeship (North-Eastern Poland). Przegl Epidemiol. 2017;71(4):547-54. https://doi.org/10.1016/j.biosystems.2018.04.005
  18. Barzgar G, Ahmadpour E, Ahmadi R, Norouzi R, Siyadatpanah A, Kohansal MH. Detection of Trichomonas vaginalis by microscopy and molecular methods in women referred to health centers in Tabriz, Northwest Iran. J Parasitol Dis. 2024;48(3):624-9. https://doi.org/10.1007/s12639-024-01703-0
  19. Ismael S. Prevalence of Trichomoniasis and Vulvovaginal Candidiasis Among Married Women in Duhok City, Kurdistan Region, Iraq. Arch Razi Inst. 2024;79(2):303. https://doi.org/10.1007/s40201-024-0203-4
  20. Rahi AA, Jaleel Ia. A Study of Trichomonas Vaginalis Infection Among Women AT Wasit Province, Iraq. Int J Health Sci (Qassim). 2022; 6(S8):3484-9. https://doi.org/10.3389/fnhum.2013.00617
  21. Kadir M, Sulyman M, Dawood I, Shams-Eldin S. Trichomonas vaginalis and associated microorganisms in women with vaginal discharge in Kerkuk-Iraq. Ankara Med J. 2014;14(3):91-9. https://doi.org/10.17098/amj.47284
  22. Ambrozio CL, Nagel AS, Jeske S, Bragança GCM, Borsuk S, Villela MM. Trichomonas vaginalis prevalence and risk factors for women in southern Brazil. Rev Inst Med Trop Sao Paulo. 2016;58:61. https://doi.org/10.1590/S1678-9946201658061
  23. Keşli R, Pektaş B, Özdemir M, Günenç O, Coşkun E, Baykan M, et al. 18-45 yaş grubu kadınlarda, Trichomonas vaginalis ve diğer mikroorganizmaların vajinal akıntı örneklerinden mikroskobik olarak incelenmesi. Turkiye Parazitol Derg. 2012;36:182-4. https://doi.org/10.5152/tpd.2012.43
  24. Van Der Pol B. Clinical and laboratory testing for Trichomonas vaginalis infection. J Clin Microbiol. 2016;54(1):7-12. https://doi.org/10.1128/JCM.02025-15
  25. Hobbs MM, Seña AC. Modern diagnosis of Trichomonas vaginalis infection. Sex Transm Infect. 2013;89(6):434-8. https://doi.org/10.1136/sextrans-2013-051057
  26. Momeni Z, Sadraei J, Kazemi B, Dalimi A. Molecular typing of the actin gene of Trichomonas vaginalis isolates by PCR-RFLP in Iran. Exp Parasitol. 2015;159:259-63. https://doi.org/10.1016/j.exppara.2015.10.011
  27. Schwebke JR, Gaydos CA, Nyirjesy P, Paradis S, Kodsi S, Cooper CK. Diagnostic performance of a molecular test versus clinician assessment of vaginitis. J Clin Microbiol. 2018;56(6):e00252-18.
  28. https://doi.org/10.1128/jcm.00252-18
  29. Polis KS, Ali BM. Knowledge of Men and Women about infertility Risk Factors. Adv Med J. 2022;7(2):93-101. https://doi.org/10.56056/amj.2022.184
  30. Shekhany KAM. Isolation and genotyping of Candida albicans involved in vaginal candidiasis among pregnant women in Sulaymaniyah and Erbil cities. Zanco J Med Sci. 2021;25(1):493-502. https://doi.org/10.15218/zjms.2021.012
How to Cite
M. Jabbary, H., Ismail Hassan , Z. ., & Mohammad Ismael , H. . (2026). Molecular detection of Trichomonas Vaginalis using 5.8S rRNA gene in reproductive-age women in Erbil city. Zanco Journal of Medical Sciences (ZJMS), 30(2), 576–586. https://doi.org/10.15218/zjms.2026.039

Send mail to Author

Send Cancel